Andrew Saik

2021 - Intercept Pharmaceuticals

In 2021, Andrew Saik earned a total compensation of $2.5M as CFO at Intercept Pharmaceuticals.

Compensation breakdown

Bonus$102,500
Non-Equity Incentive Plan$113,823
Option Awards$903,848
Salary$251,894
Stock Awards$1,086,931
Other$16,857
Total$2,475,854

Saik received $1.1M in stock awards, accounting for 44% of the total pay in 2021.

Saik also received $102.5K in bonus, $113.8K in non-equity incentive plan, $903.8K in option awards, $251.9K in salary and $16.9K in other compensation.

Rankings

In 2021, Andrew Saik's compensation ranked 5,186th out of 12,415 executives tracked by ExecPay. In other words, Saik earned more than 58.2% of executives.

ClassificationRankingPercentile
All
5,186
out of 12,415
58th
Division
Manufacturing
2,180
out of 5,505
60th
Major group
Chemicals And Allied Products
941
out of 2,375
60th
Industry group
Drugs
841
out of 2,096
60th
Industry
Pharmaceutical Preparations
604
out of 1,546
61st

Pay ratio

Andrew Saik's Pay$2,475,854
Median Employee's Pay$216,748
Pay Ratio

11

to 1

In 2021, the annual total compensation of Andrew Saik was $2,475,854.

The annual total compensation of the median employee at Intercept Pharmaceuticals was $216,748.

The ratio of Andrew Saik's pay to the pay of median employee was therefore 11 to one.

Source: SEC filing on May 2, 2022.

Saik's colleagues

We found six more compensation records of executives who worked with Andrew Saik at Intercept Pharmaceuticals in 2021.

2021

Jerome Durso

Intercept Pharmaceuticals

Chief Executive Officer

2021

Jared Freedberg

Intercept Pharmaceuticals

General Counsel

2021

Michelle Berrey

Intercept Pharmaceuticals

Chief Medical Officer

2021

Gail Cawkwell

Intercept Pharmaceuticals

SVP Medical Affairs, Safety & Pharmacovigilance

2021

Sandip Kapadia

Intercept Pharmaceuticals

Chief Financial Officer

2021

Rocco Venezia

Intercept Pharmaceuticals

Chief Financial Officer

News

You may also like